Needham & Company Sets Examworks Group Price Target at $15.00 (EXAM)

By admin | 6 years ago

Needham & Company upped their price target on shares of Examworks Group (NASDAQ: EXAM) from $13.00 to $15.00 in a research note issued on Thursday. The firm currently has a “buy” rating on the stock.

Examworks Group opened at 12.31 on Thursday. Examworks Group has a 52-week low of $6.40 and a 52-week high of $26.48. The company’s market cap is $419.7 million.

Examworks Group last posted its quarterly earnings results on Wednesday, May 9th. The company reported ($0.13) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.11) by $0.02. The company’s quarterly revenue was up 85.7% on a year-over-year basis. Analysts expect that Examworks Group will post $-0.04 EPS next quarter.

ExamWorks Group, Inc. (ExamWorks) is a provider of independent medical examinations (IMEs), peer and bill reviews, and related services, which it collectively refers to as IME services or the IME industry.

About the author